Adrenomyeloneuropathy

This code identifies a rare, inherited neurodegenerative disorder primarily affecting males, characterized by progressive spastic paraparesis, sensory ataxia, and adrenal insufficiency. It is a milder, later-onset variant of X-linked adrenoleukodystrophy (X-ALD), where the primary pathology involves demyelination in the spinal cord and peripheral nerves, and adrenal gland dysfunction.

Assign this code for patients diagnosed with adrenomyeloneuropathy, typically presenting with adult-onset neurological symptoms such as gait disturbance and weakness in the lower limbs, often accompanied by symptoms of adrenal insufficiency. Documentation should clearly specify the diagnosis of adrenomyeloneuropathy, often confirmed by genetic testing for mutations in the ABCD1 gene and elevated very long-chain fatty acids (VLCFAs).

• Distinguish from other forms of X-linked adrenoleukodystrophy (e.g., cerebral ALD) based on clinical presentation and age of onset.
• Code any associated manifestations, such as adrenal insufficiency (e.g., E27.40, E27.49), as secondary diagnoses.
• Ensure documentation supports the specific diagnosis of adrenomyeloneuropathy, as opposed to a general diagnosis of adrenoleukodystrophy.